Is Futura Medical plc (FAMDF) a Buy, Sell, or Hold?
OTC : FAMDF
Futura Medical plc — News
$0.0189 USD
$0.01 (76.64%)
- Volume
- 250
- Average Volume
- 16.67K
- Market Capitalization
- $6.41M
- P/E Ratio
- -0.15
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.20
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.06
| Source | Headline |
|---|---|
|
Futura Medical: US Eroxon deal and WSD4000 breakthrough - ICYMI
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) chief executive Alex Duggan talked with Proactive about the company's new US commercial partnership for... proactiveinvestors.com - 2026-07-11 06:38:00 |
|
Futura Medical: US Eroxon deal and WSD4000 breakthrough - ICYMI
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) chief executive Alex Duggan talked with Proactive about the company's new US commercial partnership for Eroxon and encouraging new clinical data for its women's sexual health product candidate, WSD4000. Duggan explained why Futura Medical selected Market Performance Group (MPG) as its new US commercial partner, highlighting the group's extensive experience in consumer healthcare and its role in managing commercial execution, advertising, distribution and customer operations. proactiveinvestors.co.uk - 2026-07-11 05:46:54 |
|
Exxon Mobil updates Q2 earnings considerations, cites impacts across key businesses
Exxon Mobil Corp (NYSE:XOM, XETRA:XONA) updated its second quarter 2026 earnings considerations after the market close on Tuesday, prompting UBS to slightly... proactiveinvestors.com - 2026-07-08 11:30:00 |
|
Futura to appeal European patent decision
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX), the pharmaceutical group, said it intends to appeal a European Patent Office decision to revoke its patent for MED3000, the erectile dysfunction treatment sold as Eroxon. It will take the case to the EPO Technical Board of Appeal, a process expected to take at least 18 to 24 months. proactiveinvestors.co.uk - 2026-07-08 02:44:54 |
|
Samsung plunges despite earnings beat, sparking fresh AI stock jitters for Nasdaq names
Samsung Electronics' posted a record quarterly profit on Tuesday but this failed to reassure investors, with the sharp sell-off in the world's largest... proactiveinvestors.com - 2026-07-07 03:09:00 |
|
FTSE 100 Live: Stocks slide despite airlines and defence gains, Microsoft slashes jobs
FTSE 100 down 56 points at 10,623 Pub shares rise after England World Cup win Deal news for easyJet, ITV and defence sector UK construction downturn... proactiveinvestors.com - 2026-07-06 11:34:00 |
|
FTSE 100 Live: Stocks slide despite airlines and defence gains, US tech futures rise
FTSE 100 down 26 points at 10,653 Pub shares rise after England World Cup win Deal news for easyJet, ITV and defence sector UK construction downturn... proactiveinvestors.com - 2026-07-06 08:13:00 |
|
FTSE 100 Live: London index at 10-week high as Sainsbury's, miners and banks climb
FTSE 100 up 123 points at 10,607 Miners climb on higher copper prices Sainsbury's Q1 update impresses 12.05pm: FTSE at 10-week high The FTSE 100 has... proactiveinvestors.com - 2026-06-30 08:06:00 |
|
Nasdaq leads Wall Street higher at the open as uneasy Iran truce holds
12:30pm: Tech strength The Nasdaq continued to lead stocks higher in the early afternoon on Monday, up 1.4% while the S&P 500 was up 0.8% and the Dow Jones... proactiveinvestors.com - 2026-06-29 08:30:00 |
|
Futura swaps Haleon for Market Performance Group to drive US Eroxon sales - UPDATE
Share in Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) rose 19% to 0.6p after it ended its US partnership with consumer health giant Haleon PLC (LSE:HLN,... proactiveinvestors.com - 2026-06-29 05:51:00 |
|
Futura Medical plc (FAMDF) Q4 2025 Earnings Call Transcript
Futura Medical plc (FAMDF) Q4 2025 Earnings Call Transcript seekingalpha.com - 2026-05-04 14:43:27 |
|
Microsoft Q3 results top expectations, driven by Intelligent Cloud strength
Microsoft Corp (NASDAQ:MSFT) reported fiscal third quarter earnings that exceeded Wall Street expectations, driven by continued strength in its cloud and... proactiveinvestors.com - 2026-04-29 12:25:00 |
|
Futura Medical refines strategy and evolves commercial model after tough 2025
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX), the consumer healthcare company behind erectile dysfunction gel Eroxon, said it has refined its strategy... proactiveinvestors.com - 2026-04-29 03:41:00 |
|
Futura Medical refines strategy and evolves commercial model after tough 2025
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX), the consumer healthcare company behind erectile dysfunction gel Eroxon, said it has refined its strategy and is evolving its commercial model following a comprehensive strategic review. In its full-year results statement, the told investors it is moving from a pure out-licensing structure toward a hybrid model combining research and development with direct commercial activity. proactiveinvestors.co.uk - 2026-04-29 02:46:42 |
